Highlights Alembic Limited

Equities

506235

INE426A01027

Market Closed - Bombay S.E. Other stock markets 06:00:51 2024-06-12 am EDT			5-day change	1st Jan Change
104.2 ^INR	+1.31%		+9.88%	+15.01%

May. 30	Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets	MT
May. 13	Alembic Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets	May. 30	MT
Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024	May. 13	CI
Alembic Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 13	CI
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q4	May. 09	MT
India's Alembic Pharma posts higher Q4 profit on strong N.America sales	May. 09	RE
Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3%	Apr. 18	MT
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	Apr. 02	MT
Alembic Pharmaceuticals' Oncology Plant in Gujarat, India Gets One Observation from US FDA	Mar. 11	MT
Indian shares seen muted tracking broader Asian equities	Feb. 25	RE
Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates	Feb. 06	MT
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates	Feb. 06	MT
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	Feb. 05	RE
North American Morning Briefing : Jobs Report Tops -2-	Feb. 02	DJ
North American Morning Briefing : Stock Futures -2-	Jan. 23	DJ
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit	Jan. 02	MT
Alembic Pharmaceuticals Logs Slightly Higher Consolidated Profit in Fiscal Q2; EPS Misses Estimates	Nov. 08	MT
India's Alembic Pharma Q2 profit roughly in-line with estimates	Nov. 07	RE
Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Alembic Limited

Equities

506235

INE426A01027

Highlights

Filters